Latest Industry News & Trends

Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.

Recently Added News

11/17/2026
AIDiagnosticEuropeIndustryMeetingNewsletterRetinaRoboticsSurgical
Innovation Meetings Tackle Different Facets of Retinal Care
Innovation Meetings Tackle Different Facets of Retinal Care
The two big innovation meetings at the 2026 Euretina congress in Vienna, Austria, had overlapping time slots, but they targeted different audiences. The half-day Euretina Innovation Spotlight (EIS)...
11/17/2026
Clinical TrialDeviceDiagnosticEuropeGene TherapyMeetingNewsletterOCTPharmaRetina
Euretina Congress Turns Spotlight on Possible Paradigm Shifts
Euretina Congress Turns Spotlight on Possible Paradigm Shifts
Euretina’s program committee captured the intellectual ferment in retina with several presentations challenging established paradigms. Sandrine Zweifel, MD, PhD (Switzerland), got the ball rolling ...
11/17/2026
BreakingCataractEuropeGlaucomaIndiaIndustryMeetingNewsletterRefractiveRetina
2026-2027 Ophthalmic Meetings Calendar
2026-2027 Ophthalmic Meetings Calendar
Market Scope regularly updates its list of ophthalmic meetings to keep the information current. Please contact us at matthewdouty@market-scope.com if we do not have your meeting listed. Thank you.
11/17/2026
CataractDeviceDiagnosticEuropeFundusLow VisionMeetingNewsletterOCTOptometryPharmaRetinaSurgical
Hot Topics at Euretina Congress Include Wet AMD Dosing Intervals, New Products
Hot Topics at Euretina Congress Include Wet AMD Dosing Intervals, New Products
Celine Lee, MD (Denmark), reported at the 2026 Euretina congress that 37 of 311 eyes (11.9 percent) in the Danish RIDE-AMD Initiative were able to discontinue aflibercept treatment. “In Denmark, we...
11/17/2026
AAOAIClinical TrialEyeceleratorIOLMeetingNewsletterRegulationRetina
Eyecelerator Weighs Current Problems, Potential Solutions in Innovation
Eyecelerator Weighs Current Problems, Potential Solutions in Innovation
Eyecelerator participants discussed some of the challenges holding back innovation to a room filled with attendees, despite the threat of extreme weather from Hurricane Isaias. The forum was held O...
11/17/2026
AAODeviceMeetingNewsletterRetina
Retina Specialists at AAO Meeting Weigh Benefits, Drawbacks of PBM
Retina Specialists at AAO Meeting Weigh Benefits, Drawbacks of PBM
The 2026 AAO meeting featured two full days of sessions dedicated to the retina subspecialty. These sessions covered a breadth of subjects, including surgical techniques, clinical trial updates, re...
11/17/2026
AAOInstrumentsMeetingNewsletterSingle-UseSurgical
Ambler Showcases Kinder, Gentler Pupil Expander at AAO Meeting
Ambler Showcases Kinder, Gentler Pupil Expander at AAO Meeting
Ambler Surgical showcased its new A-Flex pupil expander at the 2026 AAO meeting. Ambler claims that the A-Flex, which will begin shipping in January 2027, provides an innovative, atraumatic method ...
11/17/2026
AAODiagnosticGlaucomaMeetingNewsletterPerimetry
Headset Perimetry Gains Ground, but the Bowl Isn’t Going Away
Headset Perimetry Gains Ground, but the Bowl Isn’t Going Away
Traditional glaucoma diagnostic methods came under scrutiny at the 2026 AAO meeting’s Glaucoma Subspecialty Day as panelists weighed the reliability of established testing standards against the eff...
11/17/2026
Clinical TrialDry EyeGlaucomaNewsletterRetina
Clinical Trial Updates for Ophthalmic Candidates, November 2026
Clinical Trial Updates for Ophthalmic Candidates, November 2026
Market Scope is tracking companies that have announced clinical trial updates or milestone achievements.
11/17/2026
NewsletterRegulationRetina
US FDA Orders GLP-1 Makers to Warn of Potential for Vision Loss
US FDA Orders GLP-1 Makers to Warn of Potential for Vision Loss
The US FDA announced Nov. 9 that it would require safety labeling changes for the entire class of glucagon-like peptide-1 (GLP-1) receptor agonists, including the popular weight loss drugs Wegovy a...
11/17/2026
NewsletterOptometryScope of Practice
Alberta Is First Province in Canada to Authorize Optometric Surgery
Alberta Is First Province in Canada to Authorize Optometric Surgery
Alberta on Nov. 1 became the first province in Canada to allow qualified optometrists with additional training to perform certain minor surgical and laser procedures in their offices. Under the exp...
11/17/2026
CornealDeviceDiagnosticEmergingGlaucomaNewsletterRetinaThyroid Eye Disease
Emerging Companies Pursuing Ophthalmic Indications, November 2026
Emerging Companies Pursuing Ophthalmic Indications, November 2026
Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.

Past News Stories

11/17/2026
NewsletterOptometry
Weekly Poll of MDs and ODs, US Only, November 2026
Weekly Poll of MDs and ODs, US Only, November 2026
11/17/2026
Clinical TrialCornealDealsDiagnosticDry EyeGene TherapyIndustryNewsletterOcular CancerPerimetryPresbyopiaRegulationRetinaStudy
November 2026 Ophthalmic News Briefs
November 2026 Ophthalmic News Briefs
Volk Optical announced Oct. 7 the launch of ClearField Pro, a new lens for retinal examination and laser indirect ophthalmoscopy. The lens’ coating provides up to 77 percent less reflectivity, Volk...
11/13/2026
BreakingRegulationRetina
US FDA Orders GLP-1 Makers to Warn of Potential for Vision Loss
US FDA Orders GLP-1 Makers to Warn of Potential for Vision Loss
The US FDA announced Nov. 9 that it would require safety labeling changes for the entire class of glucagon-like peptide-1 (GLP-1) receptor agonists, including the popular weight loss drugs Wegovy a...
11/13/2026
BreakingChinaMyopiaRefractiveRegulationSurgical
Chinese Regulators Approve PT Lunana Phakic IOL from Zeiss for Myopia
Chinese Regulators Approve PT Lunana Phakic IOL from Zeiss for Myopia
German company Carl Zeiss Meditec announced on Nov. 9 that China’s National Medical Products Administration (NMPA) had approved the company’s PT Lunana phakic intraocular lens (IOL). The lens was s...
11/13/2026
BreakingCataractDry EyeGlaucomaIOLPharmaRefractiveRetinaRevenueSurgical
Q3-2026 Ophthalmic Revenue Roundup for Alcon, Harrow, STAAR Surgical, ANI, and Sight Sciences
Q3-2026 Ophthalmic Revenue Roundup for Alcon, Harrow, STAAR Surgical, ANI, and Sight Sciences
Alcon reported Nov. 10 that its Q3-2026 net sales were $2.7 billion, a 5 percent increase (+5 percent cc) over $2.6 billion in Q3-2025. Surgical net sales for implantables, consumables, and equipme...
11/13/2026
BreakingMyopiaPharmaRegulation
Santen Gains Korean Marketing Approval for Ryjusea (Atropine) for Myopia
Santen Gains Korean Marketing Approval for Ryjusea (Atropine) for Myopia
Japan’s Santen Pharmaceutical announced Nov. 2 that it had gained marketing approval in South Korea for preservative-free Ryjusea low-dose atropine drops to slow the progression of pediatric myopia...
11/13/2026
BreakingOptometryRegulationScope of Practice
Alberta Is First Province in Canada to Authorize Optometric Surgery
Alberta Is First Province in Canada to Authorize Optometric Surgery
Alberta on Nov. 1 became the first province in Canada to allow qualified optometrists with additional training to perform certain minor surgical and laser procedures in their offices. Under the exp...
11/13/2026
BreakingPresbyopiaTelehealth
Tenpoint Launches Telehealth Prescribing Option for Yuvezzi Presbyopia Drops
Tenpoint Launches Telehealth Prescribing Option for Yuvezzi Presbyopia Drops
Tenpoint Therapeutics announced Nov. 9 that it was making its presbyopia drop, Yuvezzi, available online through a telehealth platform at orderyuvezzi.com. Tenpoint said the site offers patients a ...
11/13/2026
BreakingDealsEmergingRetina
Emerging Company Imvionix Acquires Rights to Beovu in US, Canada
Emerging Company Imvionix Acquires Rights to Beovu in US, Canada
Imvionix, a privately held emerging retinal pharmaceutical company, announced Nov. 10 that it had acquired exclusive commercial rights to Beovu (brolucizumab-dbll) in the US and Canada from Novarti...
11/13/2026
BreakingRegulationRetina
US FDA Grants Orphan Drug Status to Octant’s Oral RP Candidate
US FDA Grants Orphan Drug Status to Octant’s Oral RP Candidate
Octant, of Emeryville, California, announced Oct. 27 that the US FDA had granted orphan drug status to OCT-980, an oral treatment candidate targeting retinitis pigmentosa (RP). Orphan drug designat...
11/6/2026
BiosimilarsBreakingCataractDry EyeIOLPharmaRetinaRevenueSurgicalThyroid Eye Disease
Q3-2026 Ophthalmic Revenue Roundup for Regeneron, Amgen, Hoya, Tarsus, RxSight, and Xbrane
Q3-2026 Ophthalmic Revenue Roundup for Regeneron, Amgen, Hoya, Tarsus, RxSight, and Xbrane
Regeneron of Tarrytown, New York, reported Oct. 30 that its Q3-2026 US revenue for Eylea (aflibercept) 2 mg and Eylea HD (a higher dose of aflibercept at 8 mg) was just under $1.1 billion, a 1 perc...
11/6/2026
BreakingPharma
Harrow Launches HarrowRx Platform, Accessible to Doctors Through EMRs
Harrow Launches HarrowRx Platform, Accessible to Doctors Through EMRs
Nashville, Tennessee-based Harrow reported Nov. 2 that it had launched HarrowRx, allowing eye care providers to prescribe all of Harrow’s branded products within their electronic medical record (EM...

Want to Read the Full Article?

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.